about
Fostamatinib Disodium.Targeting the tyrosine kinase signalling pathways for treatment of immune-mediated glomerulonephritis: from bench to bedside and beyond.BCAT1 controls metabolic reprogramming in activated human macrophages and is associated with inflammatory diseasesSpleen tyrosine kinase inhibition attenuates autoantibody production and reverses experimental autoimmune GN.Necrotizing and crescentic glomerulonephritis presenting with preserved renal function in patients with underlying multisystem autoimmune disease: a retrospective case series.Correlation of disease activity in proliferative glomerulonephritis with glomerular spleen tyrosine kinase expression.Ofatumumab for B cell depletion therapy in ANCA-associated vasculitis: a single-centre case series.Experimental crescentic glomerulonephritis: a new bicongenic rat model.Renal tubular disease in the era of combination antiretroviral therapy.Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis: Impact on Localized and Nonlocalized Disease.Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients.Immunodeficiency-associated renal Burkitt lymphoma.Bacterial endocarditis associated with proteinase 3 anti-neutrophil cytoplasm antibodyClustering of Anti-GBM Disease: Clues to an Environmental Trigger?Should rituximab be used to prevent relapse in patients with ANCA-associated vasculitis?Measuring the quality of end of life management in patients with advanced kidney disease: results from the pan-Thames renal audit group.Predicting Outcome in Patients with Anti-GBM Glomerulonephritis.ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap.Is there a role for TNFα blockade in ANCA-associated vasculitis and glomerulonephritis?Primary IgA nephropathy: current challenges and future prospects.Spleen Tyrosine Kinase: A Crucial Player and Potential Therapeutic Target in Renal Disease.Spleen tyrosine kinase is important in the production of proinflammatory cytokines and cell proliferation in human mesangial cells following stimulation with IgA1 isolated from IgA nephropathy patients.Anti-Glomerular Basement Membrane Disease.Anti-Glomerular Basement Membrane DiseasePeroxidasin-a Novel Autoantigen in Anti-GBM Disease?Antiglomerular Basement Membrane DiseaseRole of the Spleen Tyrosine Kinase Pathway in Driving Inflammation in IgA NephropathyAcute renal failure in diabetes: looking beyond diabetic retinopathyLong-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitisOfatumumab for B cell depletion in patients with systemic lupus erythematosus who are allergic to rituximabLong-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitisA novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitisAcute Iron Deprivation Reprograms Human Macrophage Metabolism and Reduces Inflammation In VivoComment on: A novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis: replyIgG4-related disease in a multi-ethnic community: clinical characteristics and association with malignancyA novel glucocorticoid-free maintenance regimen for anti-neutrophil cytoplasm antibody-associated vasculitis
P50
Q33405080-5CCF95EC-90EC-4DA6-912E-87F50F972C12Q33620537-EB1B9B3D-DFEA-42A8-A2A4-F827D13C5F2AQ33903923-DE362E07-DACE-4333-9679-E1E12D17DF64Q34260045-02AFE766-442A-4CB7-8050-F99DE40FE433Q35767701-CC18E03A-45EB-4D78-819D-E34D8E8FE2C5Q35809151-2C280869-3461-44A2-BFA4-69691B07218BQ37118955-8991FC83-A388-4FC4-91B5-8A5CA236744CQ37287477-E194E7E1-38E1-4500-BF03-C2904F4C34BCQ38587223-0440414C-DE8F-4B3C-80D8-D98A0EF01986Q41281665-CCBEFA65-1979-47A4-993E-AE9A8B8D8C4AQ41491056-7C9AF3D8-502D-47BB-9891-4444EA700B4FQ41639614-BE34A722-2979-4C9E-BFD0-A60DD9625DD1Q41826673-1FD73A55-77A7-4A93-A4BC-9A09A921863CQ42379434-B046B96F-26A5-47D9-BEEB-FEF16EDE9E80Q42380186-0A4F83EC-DC1A-4598-911B-FFCF198BF4F1Q46149312-4B1EC857-68A5-48C4-92EB-0133A292D422Q47433350-3D145C6D-270B-4DF9-BF23-C4AE00F7E495Q49215238-3D606C6C-A480-4A2F-8F1A-2D012CFB74C4Q51066095-C1F9E244-0768-4705-999D-79D594A3BDD7Q52309425-B53C1D2C-CACC-4D14-9A87-DBD9C4520198Q54181714-61F701C2-F93B-4CCB-8565-FDCCD701E230Q54485643-315A3062-3196-45E2-8A7C-1829E48F278EQ55508549-29582F95-5E8C-4D7D-B095-B23F78D104E2Q57025044-1D7C757C-84F3-431D-80BF-A73C52792147Q57471301-26A18CD2-A10C-4391-9BA1-2FECA03F4C83Q58567341-E1F2C50C-B519-4AD3-97A2-A87BA34B4F11Q58775138-E7A32BE6-A585-4ADB-929A-CE8D7BDB435EQ83303591-B89A39DA-FE52-4D53-97A0-352ED7621841Q87829268-9DD783FE-120A-4D73-851D-343D3F81D06CQ88120542-6A7667DE-BB2E-4B5B-8B4C-89D4A7A18ECAQ88265196-F25C8E55-A592-4CDB-B006-9246BCE6A38EQ91252812-C36E15E6-31F9-4AAE-BA1A-32D6F44E1280Q91770878-C70727A9-8CF1-4EB0-A36F-C9DDCDD1D15BQ92415125-4541720F-CFEE-4260-8596-1BA7FF66D120Q92933137-92AE4EB5-15FC-47EE-BE57-0F5EDDD053D6Q95597614-425E39A7-9093-4918-BD68-D341B1CBBC43
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Stephen Mcadoo
@ast
Stephen Mcadoo
@en
Stephen Mcadoo
@es
Stephen Mcadoo
@nl
Stephen Mcadoo
@sl
type
label
Stephen Mcadoo
@ast
Stephen Mcadoo
@en
Stephen Mcadoo
@es
Stephen Mcadoo
@nl
Stephen Mcadoo
@sl
prefLabel
Stephen Mcadoo
@ast
Stephen Mcadoo
@en
Stephen Mcadoo
@es
Stephen Mcadoo
@nl
Stephen Mcadoo
@sl
P106
P21
P31
P496
0000-0001-8260-8770